Jacobs Levy Equity Management’s Molecular Templates, Inc. MTEM Stock Holding History

Jacobs Levy Equity Management’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,383	Closed	-$292K	–	1215
2022 Q2	$292K	Sell	21,383 -2,934	-12%	-$68.6K	﹤0.01%	929
2022 Q1	$1.26M	Buy	24,317 +12,072	+99%	+$533K	0.01%	721
2021 Q4	$720K	Sell	12,245 -606	-5%	-$45.4K	﹤0.01%	789
2021 Q3	$1.29M	Sell	12,851 -2,445	-16%	-$252K	0.01%	701
2021 Q2	$1.79M	Buy	+15,296	New	+$2M	0.01%	621
2017 Q2	–	Sell	-969	Closed	-$91K	–	1033
2017 Q1	$91K	Sell	969 -589	-38%	-$55.1K	﹤0.01%	867
2016 Q4	$113K	Buy	1,558 +288	+23%	+$22K	﹤0.01%	891
2016 Q3	$142K	Buy	+1,270	New	+$174K	﹤0.01%	944
2014 Q4	–	Sell	-550	Closed	-$328K	–	936
2014 Q3	$328K	Buy	550 +400	+267%	+$277K	0.01%	663
2014 Q2	$98K	Buy	+150	New	+$99.4K	﹤0.01%	803

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Jacobs Levy Equity Management's MTEM Position: Q3 2022 in Review

Jacobs Levy Equity Management sold out of Molecular Templates, Inc. (MTEM) in Q3 2022, closing a stake of 21,383 shares — an estimated $292K sold.

Jacobs Levy Equity Management first reported a position in MTEM in Q2 2014 and held it in 10 quarters. The position peaked at $1.79M in Q2 2021. 58 funds tracked by Wall St. Rank hold MTEM as of Q3 2022.

Jacobs Levy Equity Management reported no remaining Molecular Templates, Inc. position as of Q3 2022 after selling out during the quarter.
Jacobs Levy Equity Management sold 21,383 Molecular Templates, Inc. shares in Q3 2022, an estimated $292K.
Jacobs Levy Equity Management first reported a position in Molecular Templates, Inc. in Q2 2014 and held it in 10 quarters.
Jacobs Levy Equity Management's Molecular Templates, Inc. position peaked at $1.79M in Q2 2021.
58 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2022, filed 15 Nov 2022.